Cargando…

Natural and engineered antibodies against HIV

Detalles Bibliográficos
Autor principal:	Berger, Edward A
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2006
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1716908/ http://dx.doi.org/10.1186/1742-4690-3-S1-S100

Ejemplares similares

Engineered mice and B cell lines expressing broadly neutralizing antibodies and their unmutated precursors: tools for HIV vaccinology
por: Nemazee, D, et al.
Publicado: (2012)

Engineering chemokines to develop putative anti HIV-1 agents
por: Deepu, A, et al.
Publicado: (2012)

Intratumoral characteristics of tumor and immune cells at baseline and on-treatment correlated with clinical responses to MPDL3280A, an engineered antibody against PD-L1
por: Kohrt, Holbrook, et al.
Publicado: (2013)

SHIVs, monkeys, and anti-HIV-1 neutralizing antibodies
por: Martin, Malcolm A
Publicado: (2013)

Rational engineering of Fc/Fc receptor interactions to improve antibody potency
por: Doberstein, S, et al.
Publicado: (2003)

Complement supports progression of HIV and turns neutralising antibodies at low concentration into infection enhancing antibodies
por: Dierich, Manfred P, et al.
Publicado: (2006)

Design of an HIV Env antigen that binds with high affinity to antibodies against linear, conformational and broadly neutralizing epitopes within V1/V2
por: Liao, L, et al.
Publicado: (2012)

Single-cell quantification of functional outcomes of CD16 ligation in NK cells by Fc-engineered antibodies
por: Romain, Gabrielle, et al.
Publicado: (2013)

Antibody-mediated inhibition of HIV-1 elicited by HIV-I DNA priming and boosting with heterologous HIV-1 recombinant MVA in healthy Tanzanian adults
por: Joachim, A, et al.
Publicado: (2012)

Natural antibodies and autoantibodies bind to injured tissues, activate complement and cause organ damage
por: Tsokos, GC, et al.
Publicado: (2004)

Antibody mediated protection of immunized macaques against pathogenic SHIV challenge
por: Srivastava, Indresh K, et al.
Publicado: (2006)

S04-04 OA. HIV-specific responses induced by anti-CD40 targeting antibodies
por: Loof, N, et al.
Publicado: (2009)

Identification of human monoclonal antibodies specific for CCR5 from an antibody library derived from HIV-infected long-term non-progressors
por: Zhang, Mei-Yun, et al.
Publicado: (2006)

HIV-1 envelope trimer elicits higher neutralizing antibody responses than monomeric gp120
por: Kovacs, JM, et al.
Publicado: (2012)

Monoclonal antibodies and small-molecules as distinct subclasses of CCR5-targeted therapies for HIV-1
por: Olson, William C
Publicado: (2006)

Human and chicken antibodies to CCR5-ECL1 block mucosal and systemic HIV infection
por: Lopalco, Lucia, et al.
Publicado: (2006)

Anti-tumor antibody profile analysis to harness the potentials of B cells in melanomas and the natural humoral immune response
por: Kotlan, Beatrix, et al.
Publicado: (2013)

Antimalarial chloroquine metamorphosed into antiviral agent against HIV with four modes of actions
por: Chandramohan, M, et al.
Publicado: (2012)

Novel strategy for generation of mucosal immune responses against HIV-1 following systemic vaccination
por: Kutzler, Michele A, et al.
Publicado: (2006)

OA031-05. HIV escape from natural killer cytotoxicity: Nef inhibits NKp44L expression on HIV-infected CD4+ T cells
por: Fausther-Bovendo, H, et al.
Publicado: (2009)

Identification of a clade A HIV envelope immunogen from Protocol G that elicits neutralizing antibodies to tier 2 viruses
por: Hoffenberg, S, et al.
Publicado: (2012)

Neutralization of tier-2 viruses and epitope profiling of plasma antibodies from subtype-C HIV-1 infected north Indians; implications for MPER directed HIV-1 neutralization
por: Andrabi, Raiees, et al.
Publicado: (2012)

S021-06 OA. Potent and broad neutralizing antibodies from HIV-1 non-clade B infected donor reveal a new HIV-1 vaccine target
por: Phogat, SK, et al.
Publicado: (2009)

Negative regulation of HIV-1 expression by the natural isoform C-terminus truncated STAT5 (STAT5Δ)
por: Crotti, Andrea, et al.
Publicado: (2006)

Placental Hofbauer cells assemble and sequester HIV-1 in tetraspanin and DC SIGN positive compartments that are accessible to neutralizing antibodies
por: Johnson, Erica L, et al.
Publicado: (2014)

Characterization of V1V2-specific antibodies present in broadly neutralizing plasma isolated from HIV-1 infected individuals
por: Krachmarov, C, et al.
Publicado: (2012)

The frequencies of naturally occurring protease inhibitor resistance mutations in HIV proviral sequences of drug naïve sex workers in Nairobi, Kenya and their correlation with host immune response driven positively selected mutations in HIV-1
por: Sampathkumar, Raghavan, et al.
Publicado: (2014)

OA011-03. Clusterin, a natural ligand of DC-SIGN present in human semen inhibits HIV capture and transmission by dendritic cells
por: Sabatte, J, et al.
Publicado: (2009)

Autologous T-cell therapy based on a lentiviral vector expressing long antisense RNA targeted against HIV-1 env gene influences HIV replication and evolution in vivo
por: Pasternak, Alexander, et al.
Publicado: (2013)

Shaping humoral responses against mini-libraries of HIV env antigens via lipid nanoparticle vaccine delivery
por: Hanson, MC, et al.
Publicado: (2012)

Towards gene therapy against HIV-1: new therapeutic target in gag RNA accessible to ribozymes and RNA interference molecules
por: Gatignol, A, et al.
Publicado: (2014)

Structural basis for germline gene usage of a potent class of antibodies targeting the CD4 binding site of HIV-1 gp120
por: West, AP, et al.
Publicado: (2012)

S021-05 OA. Broadly neutralizing anti-HIV-1 antibodies disrupt a hinge-related function of gp41 at the membrane interface
por: Song, L, et al.
Publicado: (2009)

Minimally invasive and surface electroporation delivery of DNA vaccines for the induction of robust humoral immune responses against HIV antigens
por: Sardesai, NY, et al.
Publicado: (2012)

Mammary pathology of the genetically engineered mouse
por: Borowsky, AD
Publicado: (2003)

Engineering mosquito population for vector control
por: Windbichler, Nikolai, et al.
Publicado: (2012)

Understanding the benign nature of natural SIV infection: Implications for AIDS pathogenesis
por: Silvestri, Guido
Publicado: (2006)

Neutralizing antibodies against human T cell leukemia virus type-I (HTLV-1) eradicate HTLV-1 in combination with autologous peripheral blood mononuclear cells via antibody-dependent cellular cytotoxicity while preventing new infection
por: Tanaka, Yuetsu, et al.
Publicado: (2014)

Measurements of total and integrated HIV DNA demonstrate sporadic blips of unintegrated HIV DNA in HIV-positive patients on HAART
por: Mexas, A, et al.
Publicado: (2010)

Current tissue engineering approaches to cartilage repair
por: Tuan, RS
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_icjhp4lb54adp948l4p92kcnbs